8.33
Zevra Therapeutics Inc Aktie (ZVRA) Neueste Nachrichten
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Schroder Investment Management Group Acquires New Position in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics, Inc. $ZVRA Holdings Boosted by Stonepine Capital Management LLC - MarketBeat
Zevra Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
How Zevra Therapeutics Inc. stock performs after earningsPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Behavioral Patterns of ZVRA and Institutional Flows - news.stocktradersdaily.com
Does Zevra Therapeutics’ (ZVRA) Board Turnover Subtly Recast Its Leadership and Capital Allocation Narrative? - simplywall.st
Why Zevra Therapeutics Inc. stock is favored by top institutionsDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Legal & General Group Plc Grows Stock Position in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics (ZVRA): Evaluating Valuation Following High-Profile Board Appointment and CFO Transition - simplywall.st
Zevra Therapeutics, Inc. Announces Director and Committee Changes, Effective as of December 2, 2025 - marketscreener.com
Zevra Therapeutics appoints Alicia Secor to board of directors; announces retirement of Wendy Dixon - marketscreener.com
Zevra Therapeutics Appoints Alicia Secor to Board - TipRanks
ZVRA FinancialsIncome Statement - Quiver Quantitative
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD - The Manila Times
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors, Announces Retirement of Wendy Dixon - Quiver Quantitative
Zevra Therapeutics Announces Board Changes - TradingView
Zevra Therapeutics (NasdaqGS: ZVRA) names Alicia Secor to board as Wendy Dixon, PhD, retires - Stock Titan
How Zevra Therapeutics Inc. (1GDA) stock valuation compares with sectorQuarterly Portfolio Report & Growth Focused Entry Reports - Newser
How Zevra Therapeutics Inc. (1GDA) stock expands through international marketsGDP Growth & Verified High Yield Trade Plans - Newser
How institutional buying supports Zevra Therapeutics Inc. stock - moha.gov.vn
Zevra Therapeutics (ZVRA): Assessing Valuation After CFO Succession News Spurs Fresh Investor Interest - simplywall.st
(ZVRA) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Zevra Therapeutics CFO Resignation Announced - The Globe and Mail
Zevra Therapeutics announces CFO transition - MSN
Will Zevra Therapeutics Inc. (1GDA) stock issue positive guidanceGlobal Markets & Daily Technical Forecast Reports - newser.com
Why Zevra Therapeutics Inc. stock could rally in 2025July 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Zevra Therapeutics Announces CFO Transition - citybiz
Zevra Therapeutics (ZVRA) CFO to Step Down, Shares Fall - GuruFocus
Zevra Therapeutics, Inc. announces CFO transition - marketscreener.com
[8-K] ZEVRA THERAPEUTICS, INC. Reports Material Event | ZVRA SEC FilingForm 8-K - Stock Titan
Zevra Therapeutics Announces Departure of CFO R. LaDuane Clifton, Effective December 31, 2025 - Quiver Quantitative
Zevra Therapeutics, Inc. Announces CFO Transition - GlobeNewswire
Zevra Therapeutics, Inc. Announces Chief Financial Officer R. LaDuane Clifton to Step Down, Effective December 31, 2025 - marketscreener.com
Visualizing Zevra Therapeutics Inc. stock with heatmapsJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock return to pre crash levelsWeekly Profit Report & Growth Focused Investment Plans - newser.com
Does Zevra Therapeutics Inc. (1GDA) stock trade below intrinsic valueEarnings Beat & Safe Entry Zone Identification - newser.com
What the charts say about Zevra Therapeutics Inc. todayQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a top hedge fund pick2025 Sector Review & High Yield Stock Recommendations - newser.com
How sentiment analysis helps forecast Zevra Therapeutics Inc.July 2025 Outlook & Short-Term High Return Strategies - newser.com
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Can Zevra Therapeutics Inc. stock beat market expectations this quarterBuy Signal & Technical Pattern Based Signals - newser.com
Will Zevra Therapeutics Inc. stock outperform growth indexesJuly 2025 Pullbacks & Pattern Based Trade Signal System - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):